Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study

Background and Purpose: Apatinib is a novel antiangiogenic agent that can target vascular endothelial cell growth factor 2. The aim of our study was to evaluate the efficacy and safety of apatinib mesylate in the treatment of advanced hepatocellular carcinoma (HCC) in the real world.Methods: We retr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhuangzhuang Zheng, Zijing Liu, Haifeng Zhang, Xiao Guo, Xiaojing Jia, Jianfeng Wang, Lingbin Meng, Ying Xin, Xin Jiang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-05-01
Colecção:Frontiers in Pharmacology
Assuntos:
apatinib
hepatocellular carcinoma
vascular endothelial growth factor-2 (VEGFR-2)
transcatheter arterial chemoembolization (TACE)
progression-free survival
overall survival
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphar.2022.894016/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados